Key result
Atrial leadless pacing proves safe and feasible in pediatric sinus node dysfunction with zero 18-month complications.
Why the study?
Sinus node dysfunction is rare in the paediatric population, and while ventricular leadless pacing has been described in children, experience with atrial leadless pacing in this population remains extremely limited.
Is atrial leadless pacemaker implantation feasible and safe in an 11-year-old patient with symptomatic congenital sinus node dysfunction?
Case Report (n=1)
No
Is atrial leadless pacemaker implantation feasible and safe in an 11-year-old patient with symptomatic congenital sinus node dysfunction?
This case demonstrates the procedural feasibility and mid-term safety of implanting an atrial leadless pacemaker in an 11-year-old child with congenital sinus node dysfunction, the youngest reported patient to receive this device.
Extends atrial leadless pacing feasibility to younger children; leaves open long-term outcomes and indications.
Background Sinus node dysfunction (SND) is rare in the paediatric population. Leadless atrial pacing represents a novel therapeutic option. To our knowledge, this case represents the youngest reported patient to receive an atrial leadless pacemaker (AVEIR AR). While ventricular leadless pacing has been described in children, atrial leadless pacing experience in this population remains extremely limited. Case Summary An 11-year-old boy with lifelong bradycardia documented since fetal life presented with exertional dyspnoea and recurrent syncopal episodes. Electrocardiography revealed nodal rhythm without sinus activity. Electrophysiological evaluation demonstrated a corrected sinus node recovery time (cSNRT) of 4800 ms and absence of chronotropic response to intravenous atropine (0.04 mg/kg IV). The patient met Class I criteria for permanent pacemaker implantation according to current paediatric pacing consensus recommendations, given symptomatic sinus node dysfunction with chronotropic incompetence. An AVEIR AR leadless pacemaker was successfully implanted at the base of the right atrial appendage with optimal electrical parameters. No procedural or 18-month follow-up complications were observed. Discussion This case demonstrates procedural feasibility of atrial leadless pacing in a carefully selected paediatric patient, with encouraging mid-term follow-up. Larger studies are required to establish long-term safety and clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Chipa et al. (2026) conducted a case report in Congenital sinus node dysfunction with chronotropic incompetence (n=1). AVEIR AR atrial leadless pacemaker implantation was evaluated on Procedural and 18-month follow-up complications. Atrial leadless pacemaker (AVEIR AR) implantation in an 11-year-old with congenital sinus node dysfunction achieved optimal electrical parameters with 0 complications over 18 months of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: